Issue Type: Payer and Supply Chain Economics Favor Higher Cost Drugs

in challenge narrative

  • Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

    Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

  • Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?

    Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?

  • Association of Rebates in Part D with Patient OOP and Federal Spending

    Association of Rebates in Part D with Patient OOP and Federal Spending

  • Reforming the Payment System for Medical Oncology

  • Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs